BioSpace News Archive

According to Precedence Research, the global surgical display market size was estimated at USD 660.1 million in 2020 and is predicted to surpass around USD 730.6 million by 2030.

Mersana Therapeutics, Inc. announced that on April 1, 2022, an authorized sub-committee of the Compensation Committee of the Board of Directors of Mersana granted inducement awards consisting of stock options to purchase an aggregate of 51,150 shares of its common stock to four new employees whose employment commenced in March 2022.

Talaris Therapeutics, Inc. (Nasdaq: TALS), today shared new data on COVID-19 outcomes among living donor kidney transplant (LDKT) patients treated in the Company’s Phase 2 trial of investigational cell therapy product FCR001 (NCT00497926).

Cytokinetics, Incorporated announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, 2022 at 11:00 AM ET.

Adverum Biotechnologies, Inc. announced that it has received feedback via a Type C meeting written response from the U.S. Food and Drug Administration related to Adverum’s planned Phase 2 trial of ADVM-022 in wet age-related macular degeneration.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation as part of the 21st Annual Needham Virtual Healthcare Conference.

Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today that it has acquired the U.S. rights to TOPROL-XL® (metoprolol succinate) and its Authorized Generic (AG) through an agreement between Melinta and New American Therapeutics Inc.

Century Therapeutics announced that Lalo Flores, Ph.D., Chief Executive Officer, will present at the 21st Annual Needham Virtual Healthcare Conference on April 13, 2022, at 10:15 AM ET and participate in a panel titled “Company Perspectives: Companies Discussing Key Features and Differentiators in the NK Cellular Therapeutics Space” on April 14, 2022, at 11:00 AM ET.

Vapotherm, Inc., announced preliminary unaudited revenue for the quarter ended March 31, 2022. The Company also announced withdrawal of its full year 2022 revenue guidance together with its full year 2022 gross margin, operating expense and adjusted EBITDA guidance.

DENTSPLY SIRONA Inc. announced that Mr. John P. Groetelaars has been appointed to its Board of Directors, increasing the size of its Board from eleven to twelve members.